BioCentury
ARTICLE | Clinical News

Aeterna Zentaris preclinical data

May 12, 2014 7:00 AM UTC

In vitro, AEZS-134 led to growth inhibition of tumor cells resistant to MEK and Raf inhibitors. Data were presented at the American Association for Cancer Research meeting in San Diego. Aeterna Zenta...